Teknova Expands Leadership Team with the Appointments of Ken Gelhaus as Chief Commercial Officer and Jennifer Henry as Senior Vice President, Marketing
10 November 2021 - 11:00PM
Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading
manufacturer of cell culture media and supplements, protein
purification buffers, and molecular biology reagents, today
announced the appointments of Ken Gelhaus as Chief Commercial
Officer (“CCO”) and Jennifer Henry as Senior Vice President,
Marketing.
“We’re truly excited that Ken and Jennifer have
chosen to join our leadership team,” said Stephen Gunstream, CEO of
Teknova. “Both of them bring uniquely valuable experience to their
roles,” he continued. “Ken knows how to build and lead successful
commercial organizations in complex life sciences businesses.
That’s what we’ve challenged him to do here at Teknova. He’ll begin
by developing a commercial function – including a sales team –
ready to drive high growth and support greater scale.”
Gunstream also explained that, in recruiting
Henry to lead the Company’s marketing efforts, “We very
deliberately looked outside the traditional life sciences space. I
hoped to attract a top-notch marketing and branding professional
who would bring a fresh, consumer-oriented perspective to Teknova’s
marketing strategy. We are fortunate to have found exactly that in
Jennifer.”
Gelhaus has more than 15 years of experience in
the life sciences and diagnostics industries. Most recently, he
served as Vice President/General Manager at BD Biosciences, where
he was responsible for the global clinical solutions business unit.
He began his career at Genentech in manufacturing operations, and
subsequently held roles of increasing responsibility at Danaher
Corporation involving marketing, strategy development, acquisition
integration, commercial operations, and sales. As CCO of Teknova,
he will lead the sales, product management, commercial operations,
and customer service teams.
For 25 years, Henry has been a brand and
marketing leader across consumer software, financial services, and
the consumer electronics industries. Most recently, she was Senior
Director of Global Brand at eBay, responsible for corporate brand
strategy, identity, and integrity. Earlier in her career, she was
part of the original iPhone launch team at Apple and held various
senior advertising and marketing roles supporting both the iPhone
and iPad devices. She also led the global marketing communications
team at Google, where she was responsible for the rebranding and
launch of Motorola's new flagship smartphones. After Google, she
joined Facebook to lead the creation and execution of global
multi-channel, integrated marketing initiatives across several core
products, including Oculus (virtual reality) and Novi (blockchain).
At Teknova, she will drive the company’s corporate brand strategy
and product marketing efforts.
About Teknova
Teknova is expediting clinical breakthroughs in
the life sciences by providing custom products and reagents for
bioprocessing, bioproduction, and molecular diagnostics. With a
focus on agility and customization, Teknova delivers research-grade
and GMP products, including cell culture media and supplements,
protein and nucleic acid purification buffers, and molecular
biology reagents for a multitude of established and emerging
applications, including cell and gene therapy, mRNA therapeutics,
genomics, and synthetic biology. Teknova's proprietary processes
enable the manufacture and delivery of high quality, custom,
made-to-order products on short turnaround times and at scale,
across all stages of development, including commercialization.
Forward-Looking Statements
Statements in this press release about future
expectations, plans and prospects, as well as any other statements
regarding matters that are not historical facts, may constitute
“forward-looking statements.” These statements include, but are not
limited to, statements relating to our long-term growth strategy,
demand for our products, expansion of our production capacity and
commercial and R&D capabilities. The words, without limitation,
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intend,” “may,” “plan,” “potential,” “predict,” “project,”
“should,” “target,” “will,” “would” and similar expressions are
intended to identify forward-looking statements, although not all
forward-looking statements contain these or similar identifying
words. These forward-looking statements are based on management’s
current expectations and beliefs and are subject to uncertainties
and factors, all of which are difficult to predict and many of
which are beyond our control and could cause actual results to
differ materially and adversely from those described in the
forward-looking statements. These risks include, but are not
limited to, those related to our cash flows and revenue growth
rate; our supply chain, sourcing, manufacturing and warehousing;
inventory management; risks related to global economic and
marketplace uncertainties related to the impact of the COVID-19
pandemic; reliance on a limited number of customers for a high
percentage of our revenue; acquisitions of other companies and
other factors discussed in the “Risk Factors” section of our most
recent periodic reports filed with the Securities and Exchange
Commission (“SEC”), all of which you may obtain for free on the
SEC’s website at www.sec.gov. Although we believe that the
expectations reflected in our forward-looking statements are
reasonable, we do not know whether our expectations will prove
correct. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof,
even if subsequently made available by us on our website or
otherwise. We do not undertake any obligation to update, amend or
clarify these forward-looking statements, whether as a result of
new information, future events or otherwise, except as may be
required under applicable securities laws.
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/febf5f28-5360-411c-a5b8-49a4cd87d772
https://www.globenewswire.com/NewsRoom/AttachmentNg/50dcb55a-c20b-4a53-80ab-6bcaa0821979
Investor Contacts
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-216-1830
Sara Michelmore
MacDougall Advisors
smichelmore@macbiocom.com
+1 781-235-3060
Media Contact
Matthew Corcoran
MacDougall Advisors
mcorcoran@macbiocom.com
+1 617-866-7350
Alpha Teknova (NASDAQ:TKNO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpha Teknova (NASDAQ:TKNO)
Historical Stock Chart
From Apr 2023 to Apr 2024